Cargando…
Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
BACKGROUND: The Australian National Antimicrobial Resistance Strategy calls for a collaborative effort to change practices that have contributed to the development of drug-resistance and for implementation of new initiatives to reduce antibiotic use. METHODS: A facilitated workshop was undertaken at...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164738/ https://www.ncbi.nlm.nih.gov/pubmed/34051866 http://dx.doi.org/10.1186/s13756-021-00953-4 |
_version_ | 1783701179425882112 |
---|---|
author | Merlo, Gregory Avent, Minyon Yarwood, Trent Smith, Bonnie van Driel, Mieke Hall, Lisa |
author_facet | Merlo, Gregory Avent, Minyon Yarwood, Trent Smith, Bonnie van Driel, Mieke Hall, Lisa |
author_sort | Merlo, Gregory |
collection | PubMed |
description | BACKGROUND: The Australian National Antimicrobial Resistance Strategy calls for a collaborative effort to change practices that have contributed to the development of drug-resistance and for implementation of new initiatives to reduce antibiotic use. METHODS: A facilitated workshop was undertaken at the 2019 National Australian Antimicrobial Resistance Forum to explore the complexity of antimicrobial stewardship (AMS) implementation in Australia and prioritise future action. Participants engaged in rotating rounds of discussion using a world café format addressing six topics relating to AMS implementation. Once all tables had discussed all themes the discussion concluded and notes were summarised. The documents were independently openly coded by two researchers to identify elements relating to the implementation of antimicrobial stewardship. RESULTS: There were 39 participants in the facilitated discussions, including pharmacists, infectious disease physicians, infection prevention nurses, and others. Participants discussed strategies they had found successful, including having a regular presence in clinical areas, adapting messaging and implementation strategies for different disciplines, maintaining positivity, and being patient-focused. Many of the recommendations for the next step involved being patient focussed and outcomesdriven. This involves linking data to practice, using patient stories, using data to celebrate wins and creating incentives. DISCUSSION: Recommendations from the workshop should be included in priority setting for the implementation of AMS initiatives across Australia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-00953-4. |
format | Online Article Text |
id | pubmed-8164738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81647382021-06-01 Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia Merlo, Gregory Avent, Minyon Yarwood, Trent Smith, Bonnie van Driel, Mieke Hall, Lisa Antimicrob Resist Infect Control Letter to the Editor BACKGROUND: The Australian National Antimicrobial Resistance Strategy calls for a collaborative effort to change practices that have contributed to the development of drug-resistance and for implementation of new initiatives to reduce antibiotic use. METHODS: A facilitated workshop was undertaken at the 2019 National Australian Antimicrobial Resistance Forum to explore the complexity of antimicrobial stewardship (AMS) implementation in Australia and prioritise future action. Participants engaged in rotating rounds of discussion using a world café format addressing six topics relating to AMS implementation. Once all tables had discussed all themes the discussion concluded and notes were summarised. The documents were independently openly coded by two researchers to identify elements relating to the implementation of antimicrobial stewardship. RESULTS: There were 39 participants in the facilitated discussions, including pharmacists, infectious disease physicians, infection prevention nurses, and others. Participants discussed strategies they had found successful, including having a regular presence in clinical areas, adapting messaging and implementation strategies for different disciplines, maintaining positivity, and being patient-focused. Many of the recommendations for the next step involved being patient focussed and outcomesdriven. This involves linking data to practice, using patient stories, using data to celebrate wins and creating incentives. DISCUSSION: Recommendations from the workshop should be included in priority setting for the implementation of AMS initiatives across Australia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-00953-4. BioMed Central 2021-05-29 /pmc/articles/PMC8164738/ /pubmed/34051866 http://dx.doi.org/10.1186/s13756-021-00953-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Merlo, Gregory Avent, Minyon Yarwood, Trent Smith, Bonnie van Driel, Mieke Hall, Lisa Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia |
title | Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia |
title_full | Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia |
title_fullStr | Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia |
title_full_unstemmed | Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia |
title_short | Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia |
title_sort | where to from here? identifying and prioritising future directions for addressing drug-resistant infection in australia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164738/ https://www.ncbi.nlm.nih.gov/pubmed/34051866 http://dx.doi.org/10.1186/s13756-021-00953-4 |
work_keys_str_mv | AT merlogregory wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia AT aventminyon wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia AT yarwoodtrent wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia AT smithbonnie wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia AT vandrielmieke wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia AT halllisa wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia |